Individualized approach to elexacaftor/tezacaftor/ivacaftor dosing in cystic fibrosis, in response to self-reported anxiety and neurocognitive adverse events: A case series

The prevalence of mental health disorders is high among people with Cystic Fibrosis. The psychological symptoms in CF are associated with poor adherence, worse treatment outcomes, and greater health utilization/cost. Mental health and neurocognitive Adverse Events (AEs) have been reported with all a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ibrahim, Hisham, Danish, Hammad, Morrissey, David, Deasy, Kevin F., McCarthy, Mairead, Dorgan, James, Fleming, Claire, Howlett, Ciara, Twohig, Sarah, Vagg, Tamara, Murphy, Desmond M., Maher, Michael, Plant, Barry J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172465/
https://www.ncbi.nlm.nih.gov/pubmed/37180712
http://dx.doi.org/10.3389/fphar.2023.1156621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172465/
https://www.ncbi.nlm.nih.gov/pubmed/37180712
http://dx.doi.org/10.3389/fphar.2023.1156621

Ejemplares similares